Contact
searchSearch
HMP Global

Atopic Dermatitis NEA Approved Features

NEA Approved Features
Mental Health Support for Patients With Atopic Dermatitis
09/06/2024
We know that the mental health burden of having atopic dermatitis is real, but are patients getting the help they need?
We know that the mental health burden of having atopic dermatitis is real, but are patients getting the help they need?
We know that the mental health...
09/06/2024
The Dermatologist
NEA Approved Features
The Impact of Atopic Dermatitis Symptoms on Mental Health
05/03/2024
When patients are aware of the connection between their mental health and their eczema symptoms, they may be more likely to seek support.
When patients are aware of the connection between their mental health and their eczema symptoms, they may be more likely to seek support.
When patients are aware of the...
05/03/2024
The Dermatologist
Jeff Yu, MD
Videos
Identification and Characterization of Clinical Phenotypes
04/29/2022
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how...
04/29/2022
The Dermatologist
NEA Approved Features
The Role of Skin Microbiome in Atopic Dermatitis
03/10/2022
The skin microbiome is complex, and its role in atopic dermatitis disease activity and heterogeneity is still being researched. Dr Peter Lio answered our questions about this association, as well as the ongoing research.
The skin microbiome is complex, and its role in atopic dermatitis disease activity and heterogeneity is still being researched. Dr Peter Lio answered our questions about this association, as well as the ongoing research.
The skin microbiome is complex,...
03/10/2022
The Dermatologist
NEA Approved Features
COVID-19 Risk and Atopic Dermatitis
02/11/2022
The pathophysiology of atopic dermatitis and the risk for COVID-19 is not completely understood. A research team from Yale University conducted a study to close this knowledge gap.
The pathophysiology of atopic dermatitis and the risk for COVID-19 is not completely understood. A research team from Yale University conducted a study to close this knowledge gap.
The pathophysiology of atopic...
02/11/2022
The Dermatologist
NEA Approved Features
How an Atopic Dermatitis Biologic May Affect COVID-19 Infection
12/08/2021
A recently published study found that patients with atopic dermatitis treated with dupilumab experienced less severe COVID-19 symptoms compared with other treatments.
A recently published study found that patients with atopic dermatitis treated with dupilumab experienced less severe COVID-19 symptoms compared with other treatments.
A recently published study found...
12/08/2021
The Dermatologist
NEA Approved Features
Defining Iatrogenic Burdens in Atopic Dermatitis
08/16/2021
Patients with atopic dermatitis and complex treatment regimens are at an increased risk of complications or ill effects, known as iatrogenic burden. Dr Raj Chovatiya explains what dermatologists should know about iatrogenic burden and how to...
Patients with atopic dermatitis and complex treatment regimens are at an increased risk of complications or ill effects, known as iatrogenic burden. Dr Raj Chovatiya explains what dermatologists should know about iatrogenic burden and how to...
Patients with atopic dermatitis...
08/16/2021
The Dermatologist
NEA Approved Features
Dupilumab for Pediatric Atopic Dermatitis: Tips From Dr Amy Paller
06/17/2021
As the first advanced therapy approved for atopic dermatitis, dupilumab offers an efficacious option for moderate to severe disease. Dr Amy Paller offers insights on how this biologic can help pediatric patients with eczema and their...
As the first advanced therapy approved for atopic dermatitis, dupilumab offers an efficacious option for moderate to severe disease. Dr Amy Paller offers insights on how this biologic can help pediatric patients with eczema and their...
As the first advanced therapy...
06/17/2021
The Dermatologist
Pop Quiz: Cardiovascular Risk and Atopic Dermatitis
NEA Approved Features
Pop Quiz: Cardiovascular Risk and Atopic Dermatitis
05/17/2021
What immune pathways are most implicated in the pathogenesis of atherosclerosis and AD, respectively?
What immune pathways are most implicated in the pathogenesis of atherosclerosis and AD, respectively?
What immune pathways are most...
05/17/2021
The Dermatologist
Quiz: Pain in Atopic Dermatitis
NEA Approved Features
Quiz: Pain in Atopic Dermatitis
03/12/2021
While itch is the most burdensome symptom of AD, pain can also cause stress and negatively affect quality of life.
While itch is the most burdensome symptom of AD, pain can also cause stress and negatively affect quality of life.
While itch is the most...
03/12/2021
The Dermatologist
Nov/Dec 2024 Cover

Current Issue

December 2024
Volume 32
Issue 8
Current Issue
Issue Archive

Popular Articles

National Rosacea Society Research Grants Deadline June 15
05/28/2015
The National Rosacea Society is currently accepting proposals for research grants to be awarded in 2015. Applications should be submitted by June 15, 2015.
The National Rosacea Society is currently accepting proposals for research grants to be awarded in 2015. Applications should be submitted by June 15, 2015.
The National Rosacea Society is...
05/28/2015
The Dermatologist
News
Biologic Psoriasis Treatment Tied to Reactivation of Chronic HBV
05/23/2017
Patients diagnosed with psoriasis and chronic hepatitis B virus infection who are treated with biologic therapies are at increased risk of viral reactivation, according to recent research.
Patients diagnosed with psoriasis and chronic hepatitis B virus infection who are treated with biologic therapies are at increased risk of viral reactivation, according to recent research.
Patients diagnosed with...
05/23/2017
The Dermatologist
Actavis to Acquire Allergan
11/17/2014
Actavis plc and Allergan, Inc. entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock
Actavis plc and Allergan, Inc. entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock
Actavis plc and Allergan, Inc....
11/17/2014
The Dermatologist
Research in Review
Examining Rosacea & Comorbidities
04/18/2017
Rosacea is common but poorly understood condition of the facial skin. New scientific studies are looking at the potential link between rosacea and various comorbidities.
Rosacea is common but poorly understood condition of the facial skin. New scientific studies are looking at the potential link between rosacea and various comorbidities.
Rosacea is common but poorly...
04/18/2017
The Dermatologist
Special Report: Current & Emerging Therapies in Dermatology
07/25/2014
07/25/2014
The Dermatologist

Subscribe

The Dermatologist Newsletter

Latest Quizzes and Trivia

Illustration of JAK1 Protein
Quiz
Test Your Knowledge: The Immunology of JAK Inhibitors
12/05/2024
12/05/2024
The Dermatologist
Gil Yosipovitch, MD
Quiz
Long-Term Efficacy of Dupilumab for Prurigo Nodularis
12/05/2024
What future research is needed to better understand the long-term efficacy of dupilumab for prurigo nodularis?
What future research is needed to better understand the long-term efficacy of dupilumab for prurigo nodularis?
What future research is needed...
12/05/2024
The Dermatologist
Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
1. What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr...
1. What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr...
1. What alternative therapies...
11/11/2024
The Dermatologist
Illustration of a T cell
QUIZ
Test Your Knowledge: The Immunology of Alopecia Areata
11/04/2024
11/04/2024
The Dermatologist
psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
Brain
Quiz
Barriers to Mental Health Support
10/10/2024
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to...
10/10/2024
The Dermatologist
AD
Quiz
QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies
09/15/2024
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein...
09/15/2024
The Dermatologist
psoriasis
Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use